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T helper 17 (Th17) cells can give rise to interleukin-
17A (IL-17A)- and interferon (IFN)-g-double-pro-
ducing cells that are implicated in development
of autoimmune diseases. However, the molecular
mechanisms that govern generation of IFN-g-pro-
ducing Th17 cells are unclear. We found that coex-
pressionof theTh1 andTh17cellmaster transcription
factors, T-bet and retinoid-related orphan receptor
gamma-t (RORgt), respectively, did not generate Th
cellswith robust IL-17 and IFN-g expression. Instead,
development of IFN-g-producing Th17 cells required
T-bet and Runx1 or Runx3. IL-12-stimulated Th17
cells upregulated Runx1, which bound to the Ifng
locus in a T-bet-dependent manner. Reciprocally,
T-bet or Runx1 deficiency or inhibition of Runx
transcriptional activity impaired the development
of IFN-g-producing Th17 cells during experimental
autoimmune encephalomyelitis, which correlated
with substantially ameliorated disease course.
Thus, our studies identify a critical role for T-bet
and Runx transcription factors in the generation of
pathogenic IFN-g-producing Th17 cells.
INTRODUCTION
CD4+Tcells are amultipotent populationof cells,which are able to
differentiate into several different T helper (Th) cell subsets de-
pendingon the transcription factors that theyexpressandcytokine
signals that they receive during activation by innate immune cells.
DevelopmentofTh1cells is regulatedbytheTh1-cell-specific tran-
scription factorT-bet (Szaboet al., 2000)whereas the transcription
factors retinoid-related orphan receptor gamma-t (RORgt) and
RORa specify the Th17 cell lineage (Ivanov et al., 2006; Yang
et al., 2008). Th1 cells produce interferon-g (IFN-g) and are bestequipped to clear intracellular bacteria and viruses, whereas
Th17 cells produce interleukin-17A (IL-17A), IL-17F, IL-21, and
IL-22 to protect mucosal surfaces against extracellular bacteria
and fungi (Kaufmann, 1993;Khaderetal., 2009).However,deregu-
lated Th cell responses can increase susceptibility to autoimmu-
nity. In particular, overactive Th1 and Th17 cell responses have
been linked strongly to the development of autoimmune diseases
(Domingues et al., 2010; Ja¨ger et al., 2009; Kroenke et al., 2008;
Luger et al., 2008; Siffrin et al., 2010; Stromnes et al., 2008; Wald-
burger et al., 1996). Adoptive transfers of in vitro differentiated Th1
and Th17 cells with TCR specificities for self-antigens have
demonstrated that each subset is able to induce disease in animal
models of autoimmunity, although disease severity was highest if
both Th cell subsets were present (Domingues et al., 2010). Th17
cells show a high degree of developmental flexibility, and when
exposed to IL-12 or IL-23, they can rapidly acquire effector func-
tions that are normally associated with Th1 cell responses such
as IFN-g production (Hirota et al., 2011; Lee et al., 2009; Mukasa
et al., 2010; Muranski et al., 2011). The developmental flexibility
of Th17 cells and their shift to a Th1 cell-like phenotype has been
linked to the pathogenicity of Th17 cells in colitis (Ahern et al.,
2010; Lee et al., 2009), Crohn’s disease (Annunziato et al., 2007),
arthritis (Nistala et al., 2010), diabetes (Bendinget al., 2009), exper-
imental autoimmune encephalomyelitis (EAE) (Hirota et al., 2011),
and multiple sclerosis (Kebir et al., 2009). However, the transcrip-
tion factor network that promotes the genetic plasticity of Th17
cells has not been fully defined.
The current study was undertaken to identify which transcrip-
tion factors are required for the development of Th1-like Th17
cells. We report that coexpression of Th17 and Th1 cell master
transcription factors RORgt and T-bet, respectively, was not
sufficient to generate Th cells with strong dual Th17 and Th1
cell features. Instead, thedevelopment of Th cells that coproduce
IL-17A and IFN-g was dependent on T-bet, Runx1, and Runx3
transcription factors. Chromatin immunoprecipitation (ChIP)
analysis revealed that Runx1 bound to the Ifng promoter and
conserved regulatory elements within the Ifng locus in a T-bet-
dependent manner, resulting in the acquisition of IFN-g produc-
tion. Indeed, ectopic expression ofRunx1orRunx3wassufficientImmunity 40, 355–366, March 20, 2014 ª2014 Elsevier Inc. 355
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Figure 1. T-bet and RORgt Coexpression Is Not Sufficient for the Generation of Th1-like Th17 Cells
Flow cytometry analysis of CD4+ T cells transduced with various combinations of retroviruses expressing GFP, Thy1.1, T-bet-Thy1.1, or RORgt-GFP (above
plots). Cells were stimulated with PMA and ionomycin for 4 hr before intracellular cytokine staining for IL-17A and IFN-g. Numbers in quadrants indicate percent
IL-17A-producing and IFN-g-producing cells within GFP+Thy1.1+ gate. Data are representative of two independent experiments.
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Generation of IFN-g-Producing Th17 Cellsto promote the development of IFN-g-producing Th17 cells in the
absence of IL-12 or STAT4. Reciprocally, Runx1 deficiency or in-
hibition of Runx transcriptional activity prevented conversion of
Th17 cells into Th1-like cells either in response to IL-12 or during
EAE. Thus, this study identifies a critical role of Runx transcription
factors in the generation of Th1-like Th17 cells.
RESULTS
T-bet and RORgt Coexpression Is Not Sufficient for the
Generation of Th1-like Th17 Cells
Th17 cells demonstrate a high degree of developmental flexi-
bility, often acquiring qualities of Th1 cells through mechanisms
that are not yet fully understood. Exposure of Th17 cells to IL-12
or IL-23 results in the upregulation of the Th1-cell-lineage-spec-
ifying transcription factor T-bet and their deviation into Th1-like
cells (Hirota et al., 2011; Lee et al., 2009). Published studies
have described CD4+ Th cells that simultaneously produce
IL-17A and IFN-g and stably coexpress RORgt and T-bet
(IL-17A+IFN-g+ or Th1-like Th17 cells) (Annunziato et al., 2007;
Boniface et al., 2010; Cohen et al., 2011; Kebir et al., 2009).
Such observations led to a hypothesis that coexpression of
RORgt and T-bet results in a hybrid gene expression profile,
which would create CD4+ T cell phenotypes with features of
Th17 and Th1 cells (Oestreich and Weinmann, 2012). To directly
test this hypothesis, we transduced CD4+ T cells with retrovi-
ruses expressing RORgt and T-bet under Th17-cell-polarizing
conditions and asked whether the coexpression of master regu-
lators of Th17 and Th1 cell differentiation programs was suffi-
cient for the generation of IL-17A+IFN-g+ cells. Consistent with
previously published results (Lazarevic et al., 2011; Zhang
et al., 2008), retroviral transduction of CD4+ T cells with RORgt
alone promoted the differentiation of Th17 cells, whereas T-bet
expression effectively blocked Th17 cell lineage commitment.
Simultaneous expression of RORgt and T-bet did not result in
the generation of IL-17A+IFN-g+ cells (Figure 1). Similarly, T-bet
overexpression in established Th17 cells did not induce a IL-
17A+IFN-g+ state (data not shown). The inability of RORgt and
T-bet coexpression to generate Th17 cells with Th1-like features
suggests that coexpression of master transcription factors in
CD4+ T cells is not sufficient to explain the flexibility of Th17 cells.356 Immunity 40, 355–366, March 20, 2014 ª2014 Elsevier Inc.Runx1 and Runx3 Drive Th1-like Th17 Cell
Differentiation
To identify which transcription factor(s) could promote the devel-
opment of Th1-like Th17 cells, we took advantage of the fact that
exposure of committed Th17 cells to IL-12 results in a rapid induc-
tionof IFN-ganddeviation toaTh1-likephenotype (Leeetal.,2009;
Mukasa et al., 2010). As expected, reactivation of committed Th17
cells in the presence of IL-12 resulted in their conversion to
IL-17A+IFN-g+ and IFN-g+ cells (Figure S1 available online). IL-12
treatment substantially upregulated Ifng expression by committed
Th17cells, althoughmRNAandprotein expressionwas lower than
thatobserved inTh1cells.Under theseconditions,Th17and IL-12-
treated Th17 cells expressed similar amounts of Il17a transcripts
(Figure S1). Therefore, we generated a heterogeneous popula-
tion of IFN-g-producing cells from polarized Th17 cells without
completely extinguishing their IL-17A expression.
We next sought to determine which transcription factors were
upregulated in Th17 cells after IL-12 treatment that could ac-
count for the generation of Th1-like Th17 cells. To ensure that
we started with a homogeneous population of IL-17A-producing
Th17 cells, we used previously described Il17fThy1.1/Thy1.1 re-
porter mice in which Thy1 was introduced into the endogenous
Il17f gene (Lee et al., 2009). The IL-17F Thy1.1 reporter is ex-
pressed early in Th17 cell development, thus marking with high
accuracy almost all IL-17A-producing cells, whereas IFN-g-pro-
ducing Th1 cells did not express the reporter (Figure 2A). Naive
CD4+ T cells were isolated from Il17fThy1.1/Thy1.1 mice and acti-
vated under Th17-cell-polarizing conditions. On the sixth day
of culture, sorted Thy1.1+ and Thy1.1 cells (Figure 2B, >99%
purity) were reactivated in the presence of IL-12 for 48 hr. In
agreement with previous results (Lee et al., 2009), sorted IL-
17-producing Th17 cells gave rise to IL-17A+IFN-g+ and IFN-g+
cells whereas Thy1.1 cells gave rise predominantly to IFN-g+
cells when reactivated in the presence of IL-12 (Figure 2B). The
conversion of IL-12-stimulated Th17 cells into IL-17A+IFN-g+
and IFN-g+ cells was accompanied by increased expression of
mRNA encoding the transcription factors Tbx21, Eomes,
Runx1, and Runx3 (Figure 2C), all of which have been previously
linked to regulation of Ifng. To investigate whether these tran-
scription factors can replace IL-12 in shifting the phenotype of
Th17 cells to Th1-like cells, we transduced CD4+ T cells with
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Figure 2. Conversion of Th17 Cells into IL-17A+IFN-g+ and IFN-g+ Cells after IL-12 Treatment Is Accompanied by Induction of Tbx21, Eomes,
Runx1, and Runx3 Expression
(A) Naive CD4+ T cells were sorted from Il17fThy1.1/Thy1.1 mice and cultured under Th1- or Th17-cell-polarizing conditions for 5 days. Recovered cells were
stimulated with PMA and ionomycin for 4 hr and stained for cell surface Thy1.1 and CD4 and intracellular IL-17A and IFN-g. Numbers in quadrants indicate
percent Thy1.1-positive, IL-17A-producing, and IFN-g-producing cells within CD4-positive gate. Data are representative of two independent experiments.
(B) Naive CD4+ T cells were sorted from Il17fThy1.1/Thy1.1 mice and cultured under Th17-cell-polarizing conditions for 5 days. Recovered cells were stained with
anti-Thy1.1 antibody and sorted into Thy1.1+ and Thy1.1 fractions (>99%purity). Thy1.1+ and Thy1.1 cells were washed and reactivated on anti-CD3 andCD28
antibody-coated plates in the presence of IL-12 alone (5 ng/ml). Cells were cultured for 3 days and stained for cell-surface CD4 and intracellular IL-17A and IFN-g
after PMA and ionomycin stimulation for 4 hr. Numbers in quadrants represent the percentage of IL-17A-producing and IFN-g-producing cells within CD4+ gate.
Data are representative of two independent experiments.
(C) Quantitative RT-PCR analysis of Tbx21, Eomes, Runx1, and Runx3 mRNA isolated from Thy1.1+ cells that were reactivated under Th17-cell-polarizing
conditions or in the presence of IL-12 alone. Data are representative of two independent experiments (mean ± SEM of replicate wells).
See also Figure S1 and Table S1.
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Generation of IFN-g-Producing Th17 Cellsretroviruses expressing T-bet, Eomes, Runx1, or Runx3 under
Th17-cell-polarizing conditions. Consistent with published re-
ports (Ichiyama et al., 2011; Lazarevic et al., 2011), overexpres-
sion of T-bet or Eomes constrained Th17 cell differentiation.
However, neither T-bet nor Eomes induced development of IL-
17A+IFN-g+ cells (Figures 3A and 3B). Ectopic expression of
Runx1 or Runx3 promoted differentiation of not only IL-17A+
cells but also a significant proportion of IL-17A+IFN-g+ and
IFN-g+ cells (Figures 3A and 3B). Thus, Runx1 and Runx3 are
able to replace IL-12 in promoting the generation of Th1-like
Th17 cells. Mechanistically, overexpression of Runx1 or Runx3
in Th17 cells resulted in the induction of Stat4 and Tbx21, known
downstream factors of IL-12 signaling (Figure 3C). Runx1 was a
stronger activator of Tbx21 and Stat4 than Runx3, resulting in
higher amounts of Ifng mRNA and a higher frequency of IFN-g-producing cells (Figure 3). STAT4 and T-bet epigenetically
silence the Rorc locus in Th17 cells (Mukasa et al., 2010). Both
Runx1 and Runx3 maintained high Rorc expression despite
elevated expression of Tbx21 and Stat4. These results demon-
strate that high expression of RORgt, T-bet, and especially
Runx1 (or Runx3) are needed to stabilize the IL-17A+IFN-g+
mixed phenotype (Figure 3C).
T-bet and Runx3 interact and functionally cooperate to induce
maximal IFN-g production in Th1 cells (Djuretic et al., 2007), and
we have shown previously that T-bet and Runx1 interact in pri-
mary CD4+ T cells (Lazarevic et al., 2011). Based on these find-
ings, we sought to determine whether the formation of T-bet and
Runx1 or T-bet and Runx3 transcriptional complexes was
required for Runx-mediated conversion of Th17 cells into Th1-
like Th17 cells. To address this question, we expressed Runx1Immunity 40, 355–366, March 20, 2014 ª2014 Elsevier Inc. 357
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Figure 3. Runx1 and Runx3 Promote Differentiation of Th1-like Th17 Cells
(A) Naive CD4+ T cells were sorted fromWTmice, activated, and transduced with retroviruses expressing GFP, T-bet-GFP, Eomesodermin-GFP, Runx1-GFP, or
Runx3-GFP (above plots) under Th17-cell-polarizing conditions. Cells were stimulated with PMA and ionomycin for 4 hr and stained for intracellular IL-17A and
IFN-g. Numbers in quadrants represent the percentage of IL-17A-producing and IFN-g-producing cells within GFP+ gate. The data are representative of five
independent experiments.
(B) The bars represent mean ± SEM of cytokine-producing cells within GFP+ cells from five independent experiments (as described in A).
(legend continued on next page)
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Generation of IFN-g-Producing Th17 Cellsor Runx3 in WT or T-bet-deficient (Tbx21/) Th17 cells. Both
Runx1 and Runx3 promoted differentiation of Th1-like Th17 cells
in both the presence and absence of T-bet, as shown by the fact
that similar percentages of IL-17A+, IL-17A+IFN-g+, and IFN-g+
cells were detected in Tbx21/ and WT cultures (Figure 3D).
However, Tbx21/ Th17 cells transduced with Runx1- or
Runx3-expressing retroviruses had diminished Ifng transcription
and IFN-g protein compared to WT controls (Figure 3E), indi-
cating that Runx transcription factors were dependent on
endogenous T-bet expression for maximal induction of IFN-g
production in Th17 cells. In fact, coexpression of T-bet and
Runx1 or T-bet and Runx3 in Th17 cells resulted in the highest
frequency of IFN-g-producing cells and higher amounts of Ifng
mRNA and IFN-g protein than when either transcription factor
was overexpressed alone (Figure S2). Similar amounts of Ifng
mRNA and IFN-g protein were produced by Stat4/ and WT
Th17 cells after transduction with Runx1- and Runx3-expressing
retroviruses, demonstrating that STAT4 was not required for
Runx-mediated generation of Th1-like Th17 cells (Figures 3F
and 3G). Based on these results, we conclude that expression
of either Runx1 or Runx3 is sufficient to promote the differentia-
tion of Th cells with Th1 and Th17 cell characteristics in the
absence of IL-12 or STAT4; however, maximal Ifng transcription
and IFN-g protein expression by Th17 cells requires both T-bet
and Runx transcription factors.
Conversion of Committed Th17 Cells to Th1-like Cells
Requires T-bet and Runx
To assess whether T-bet and Runx transcription factors were
essential for IL-12-mediated conversion of Th17 cells into IFN-
g-producing cells, we examined the effects of T-bet and Runx
deficiency on the ability of polarized Th17 cells to convert into
Th1-like cells after exposure to IL-12. Because Runx1 is required
for the survival of CD4+ T cells, in part by regulating IL-7Ra
expression, and Runx1-deficient mice have a substantial reduc-
tion in peripheral CD4+ T cells (Egawa et al., 2007), we intro-
duced the prosurvival Bcl2 transgene into Cd4-cre Runx1fl/fl
and Runx1fl/fl mice. We found that Runx1-deficient CD4+
T cells differentiated poorly into Th17 cells (Figure 4A), which is
consistent with a previously reported role of Runx1 in the differ-
entiation of Th17 cells (Zhang et al., 2008). Isolated deletion of
T-bet, Runx1, or Runx3 in CD4+ T cells markedly diminished
the Th17 to Th1 cell conversion after IL-12 treatment, as
evidenced by a decreased percentage of IL-17A+IFN-g+ and
IFN-g+ cells and reduced Ifng mRNA expression (Figures 4A
and 4B). Based on these results, we conclude that T-bet,
Runx1, and Runx3 are all critical for IL-12-induced conversion
of differentiated Th17 cells into IFN-g-producing cells.
Recently, several studies have shown the importance of IL-23
and IL-1b in the ontogeny of pathogenic Th1-like Th17 cells(C) Quantitative RT-PCR analysis of Ifng, Il17a, Tbx21, Stat4, and RorcmRNA isol
GFP, or Runx3-GFP. The data are representative of three independent experime
(D–G) Cytokine production by WT and Tbx21/ Th17 cells (D) and WT and Stat4
Runx3-GFP (above plots). Numbers in quadrants indicate percent IL-17A-produc
of IfngmRNA and intracellular staining of IFN-g protein in Tbx21/ andWT Th17
expressing retrovirus. The bars represent mean ± SEM of replicate wells. Abbrev
three independent experiments.
See also Figure S2.(Chung et al., 2009; Ghoreschi et al., 2010; Hirota et al., 2011;
Lee et al., 2009). To determine whether Runx1 and Runx3
expression was also induced upon IL-23 or IL-1b treatment,
we reactivated established Th17 cells in the presence of Th17-
cell-skewing cytokines (IL-6+TGF-b), IL-12 alone, IL-23 alone,
or IL-1b alone. Similar to IL-12, IL-23 and IL-1b enhanced
Runx1 and Runx3 expression in Th17 cells (Figure S3). These
results suggest that the upregulation of Runx1 and Runx3 may
be a central component in the generation of Th1-like Th17 cells
in response to multiple cytokines.
Runx1 Binds to the Ifng Locus in a T-bet-Dependent
Manner
Our experiments showed that conversion of Th17 cells into Th1-
like Th17 cells required expression of three transcription factors:
T-bet, Runx1, and Runx3. In addition, the ability of Runx1 and
Runx3 to induce maximal IFN-g production by Th1-like Th17
cells was dependent on endogenous T-bet expression. These
observations prompted us to investigate the relationship be-
tween T-bet and Runx transcription factors in the IL-12-stimu-
lated transition of Th17 cells into IFN-g-producing cells. T-bet
is the key transcriptional activator of Ifng, and the ability of
Runx3 to enhance T-bet-mediated activation of Ifng in Th1 cells
is documented (Djuretic et al., 2007). Hence, one possibility is
that the Runx transcription factors act as coactivators to
enhance T-bet-mediated transcriptional activity at the Ifng locus
in Th17 cells. However, because Runx1 and Runx3 can induce
IFN-g expression in T-bet-deficient Th17 cells (Figures 3D and
3E), Runx transcription factors might be directly involved in regu-
lating Ifng expression in Th17 cells.
The Ifng promoter and the nine conserved noncoding
sequences (CNSs) located at 54 kb, 34 kb, 22 kb,
6 kb, +17–19 kb, +30 kb, +40 kb, +46 kb, and +54 kb from
the Ifng start site have regulatory functions that ensure proper
IFN-g expression in Th1 cells (Balasubramani et al., 2010; Hatton
et al., 2006; Shnyreva et al., 2004). The Ifng promoter and
54 kb, 34 kb, 6 kb CNSs are epigenetically silenced in
Th17 cells (Mukasa et al., 2010). However, these regulatory ele-
ments acquire permissive epigenetic modifications in a T-bet-
and STAT4-dependent manner after IL-12 treatment of Th17
cells (Mukasa et al., 2010). To determine whether Runx1 binds
to the Ifng promoter and the regulatory elements in IL-12-treated
Th17 cells, we performed ChIP analysis of Runx1 precipitated
from nuclear lysates that had been isolated from Th17 or
IL-12-treated Th17 cells. We focused our analysis on the Ifng
promoter and the 54 kb, 34 kb, 6 kb regulatory elements,
because their change from repressive to permissive state in
response to IL-12 treatment is dependent on T-bet, and on
the 22 kb and +17–19 kb CNSs, which are partially accessible
in Th17 cells (Mukasa et al., 2010). We foundmarked enrichmentated fromWT Th17 cells transduced with retroviruses expressing GFP, Runx1-
nts (mean ± SEM of replicate wells).
/ Th17 cells (F) transduced with retroviruses expressing GFP, Runx1-GFP, or
ing and IFN-g-producing cells within GFP+ gate. Quantitative RT-PCR analysis
cells (E) and WT and Stat4/ Th17 cells (G) transduced with Runx1- or Runx3-
iation: MFI, mean fluorescence intensity. The data are representative of two to
Immunity 40, 355–366, March 20, 2014 ª2014 Elsevier Inc. 359
BA
Figure 4. Runx1, Runx3, and T-bet Regulate the Conversion of Th17 to Th1-like Cells in Response to IL-12 Signaling
(A) Naive CD4+ T cells from Cd4-cre Tbx21fl/fl, Cd4-cre Runx1fl/fl (on Bcl2 transgenic background), or Cd4-cre Runx3fl/fl mice and their respective controls were
cultured under Th17-cell-polarizing conditions for 5 days. Recovered cells were washed, and one half of the recovered cells was reactivated on anti-CD3
and -CD28 antibody-coated plates under Th17-cell-polarizing conditions whereas the second half of the cells was reactivated in the presence of IL-12 alone
(5 ng/ml) for 3 days. Numbers in quadrants indicate percent IL-17A-producing and IFN-g-producing cells within CD4+ gate. Data are representative of three
independent experiments.
(B) Quantitative RT-PCR analysis of Ifng mRNA from cultures as described in (A). Data are representative of three independent experiments (mean ± SEM of
replicate wells).
See also Figure S3.
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Generation of IFN-g-Producing Th17 Cellsof Runx1 binding to the Ifng promoter and54 kb,34 kb,6 kb
CNSs within the Ifng locus only in Th17 cells treated with IL-12
(Figure 5A). We also detected a modest binding of Runx1 to
the partially accessible 22 kb and +17–19 kb CNSs in Th17
cells, which was further enriched by IL-12 treatment (Figure 5A).
No significant Runx1 binding was observed at the Ifng promoter
and 54 kb, 34 kb, 6 kb CNSs in WT Th17 cells, in IL-12-
treated Runx1-deficient Th17 cells, or in the control ChIP with
immunoglobulin G (IgG) (Figure 5A). These data establish that
Runx1 operates directly at the Ifng locus in IL-12-treated Th17
cells to promote IFN-g expression by transitioned Th17 cells.
To determine whether Runx1 binding to the Ifng promoter and
conserved regulatory elements was dependent on T-bet-medi-
ated epigenetic changes after IL-12 treatment, we performed
Runx1-specific ChIP on nuclear lysates from T-bet-deficient
and WT Th17 and IL-12-treated Th17 cells. We found that bind-
ing of Runx1 to the Ifng promoter and to the 54 kb, 34 kb,
6 kb CNSs in IL-12-treated Th17 cells was strictly dependent
on T-bet, whereas binding of Runx1 to the 22 kb and +17–360 Immunity 40, 355–366, March 20, 2014 ª2014 Elsevier Inc.19 kb CNSs was mostly T-bet independent (Figure 5B). These
results demonstrate that Runx1 binding to the Ifng locus is
dependent on T-bet at specific sites in the Ifng locus that are
normally silenced in Th17 cells and that require T-bet to become
accessible for transcription after IL-12 treatment.
T-bet and Runx Control Th17 to Th1 Cell Conversion in
Passive EAE Model
To determine whether T-bet was required for the conversion of
Th17 cells into Th1-like Th17 cells during an inflammatory
response in vivo, we examined the fate of polarized, T-bet-defi-
cient Th17 cells in the adoptive transfer model of EAE. 2D2 WT
and 2D2 Tbx21/ CD4+ T cells were cultured under Th17 cell
conditions in the presence of IL-23, reactivated on anti-CD3-
and anti-CD28-coated plates, and transferred into recipient
mice. At 17 days after transfer, 2D2 WT and 2D2 Tbx21/
CD4+ T cells were isolated from the central nervous system
of recipient mice and assayed for cytokine expression. The
majority of transferred 2D2 WT CD4+ Th17 cells converted into
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Figure 5. Runx1 Binds to the Ifng Locus in
IL-12-Treated Th17 Cells in a T-bet-Depen-
dent Manner
ChIP analysis of Runx1 binding in Th17 cells that
were reactivated under Th17-cell-polarizing con-
ditions or in the presence of IL-12 alone (as
described in Figure 4A).
(A) Runx1-specific binding to Tcrb enhancer, Actb
gene, and Ifng promoter and conserved non-
coding sequences (CNSs) within the Ifng locus in
Th17 and IL-12-treated Th17 cells. Tcrb enhancer
was used as a positive control. Actb promoter,
ChIP with IgG control antibody, and ChIP with
Runx1-specific antibody on Runx1-deficient cells
(Cd4-cre Runx1fl/fl) were used as negative con-
trols. Results are presented as percent of input
DNA. Data are representative of two independent
experiments (mean ± SEM of replicate wells).
(B) Runx1-specific binding to the Ifng promoter
and CNSs within the Ifng locus in WT and T-bet-
deficient Th17 and IL-12-treated Th17 cells. Data
are representative of two independent experi-
ments (mean ± SEM of replicate wells).
Immunity
Generation of IFN-g-Producing Th17 CellsIL-17A+IFN-g+ and IFN-g+ cells, suggesting that the shift in
cytokine production occurred in the recipient mice during EAE
(Figure 6A). The conversion of IL-17A-producing Th17 cells into
IFN-g-producing cells did not occur in the absence of T-bet.
Adoptively transferred 2D2 Tbx21/ Th17 cells were not patho-
genic and failed to induce EAE in recipient mice, which corre-
lated with significantly reduced frequencies of IL-17A+IFN-g+
and IFN-g+ cells compared to WT controls (Figure 6A). Thus,
the in vivo conversion of Th17 cells into IL-17A+IFN-g+ and
IFN-g+ cells and their pathogenic potential is dependent on
T-bet expression.
To further evaluate the role of Runx transcription factors in the
functional plasticity of Th17 cells, we specifically disrupted the
DNA binding activity of Runx transcription factors by using a
retrovirus overexpressing the Runt domain with dominant-nega-
tive activity. With this experimental system, we effectively
blocked transcriptional activity of both Runx1 and Runx3 in Th
cells. Because Runx1 is required for the survival and functional
fitness of CD4+ T cells (Egawa et al., 2007), we introduced the
prosurvival Bcl2 transgene into 2D2 WT mice (2D2 Bcl2+). CD4+
T cells isolated from 2D2 Bcl2+ mice were transduced with either
empty retrovirus (EV) or retrovirus expressing the Runt domain
(Runx DN). Overexpression of Runx DN resulted in a reduced fre-
quency of IL-17A-producing 2D2 Th17 cells prior to transfer, indi-
cating that the Runt domain interfered with the activity of Runx1
as a positive regulator of Th17 cell differentiation (Figure 6B). At
17 days after transfer, a significant percentage of IL-17A+IFN-
g+ and IFN-g+ cells was detected in the central nervous system
of mice that received 2D2 Bcl2+ Th17 cells transduced with the
empty vector. In contrast, inhibition of Runx transcriptional activ-
ity resulted in a significant reduction in the frequency of IL-17A+Immunity 40, 355–36and IL-17A+IFN-g+ cells. Consistent with
this result, adoptively transferred 2D2
Bcl2+ Th17 cells expressing Runx DN
induced mild EAE in recipient mice (Fig-
ure 6B). Because the Runt domain mayhave effects unrelated to endogenous Runx protein functions,
we deleted Runx1 from MOG35-55-reactive CD4
+ Th17 cells by
using Cre-expressing retrovirus. CD4+ T cells were isolated
fromRunx1fl/flmice immunizedwithMOG35-55 andCFAand reac-
tivated in vitro with MOG35-55 peptide and IL-23 to expand the
population of MOG35-55-reactive Th17 cells. Activated CD4
+
T cells were transduced with Cre-expressing retrovirus to induce
Runx1 gene deletion or empty vector control. Both Runx1-ex-
pressing and Runx1-deficient cells (as marked by GFP expres-
sion) CD4+ T cells were sorted and injected into the same host
(Rag2/Ilr2g/) at a 1:1 ratio. After 16 days, the cells were iso-
lated from the central nervous system of recipient mice and
IL-17A and IFN-g production by transferred CD4+ T cells was
analyzed by intracellular cytokine staining. CD4+ T cells lacking
functional Runx1 (GFP+) expanded less efficiently in a competi-
tive setting compared to Runx1-expressing CD4+ T cells,
confirming previously published data (Egawa et al., 2007). Never-
theless, we observed that the frequency of IL-17A+IFN-g+ cells
was substantially reduced inGFP+Cre-expressingRunx1fl/fl cells
compared to Runx1fl/fl control cells (Figure S4). Collectively,
these results demonstrate a requirement for both T-bet and
Runx transcription factors in the generation of pathogenic
IL-17A+IFN-g+ cells.
Th17, Th1-like Th17, and Th1 cells are readily detected in the
central nervous system of WT mice after active immunization
with MOG35-55 and CFA. To determine whether Th1-like Th17
cells are generated in the absence of T-bet, Runx1, or Runx3
during active EAE, we immunized mice with Cd4-cre-specific
deletions of T-bet, Runx1, or Runx3 and their respective controls
with MOG35-55 and CFA, and we analyzed cytokine production
by central-nervous-system-infiltrating CD4+ T cells at the peak6, March 20, 2014 ª2014 Elsevier Inc. 361
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Figure 6. Runx1 Transcription Factors and T-bet Are Required for Conversion of Th17 Cells into Th1-like Cells in the Adoptive Transfer EAE
Model
(A) Flow cytometry analysis of 2D2 WT and 2D2 Tbx21/ Th17 cells before and 17 days after adoptive transfer into C57BL/6 recipients. Bar graphs represent
percent of cytokine-producing cells within 2D2 TCR transgenic-positive CD4+ T cell population isolated from the central nervous system of the recipient mice.
Graphs represent combined data of two independent experiments with eight mice per experimental group (mean ± SEM; p values as determined by unpaired
Student’s t test). Mean clinical score of mice that received 2D2 WT or 2D2 Tbx21/ Th17 cells is shown.
(B) Flow cytometry analysis of 2D2 WT (on Bcl2 transgenic background) Th17 cells transduced with empty vector (EV) or Runx dominant-negative (Runx DN)-
expressing retrovirus, before and 17 days after adoptive transfer into T-cell-deficient (Rag2/Il2rg/) recipients. Retrovirally transduced CD4+ Th17 cells (GFP+)
were sorted prior to injection into recipient mice. Bar graphs represent percent of cytokine-producing cells within 2D2 TCR transgenic-positive CD4+ T cell
population isolated from the central nervous systemof the recipient mice. Graphs represent combined data of two independent experiments with six to eightmice
per experimental group (mean ± SEM; p values as determined by unpaired Student’s t test). Mean clinical score of mice that received 2D2 WT Th17 cells
transduced with empty vector (EV) or Runx DN-expressing retrovirus is shown.
See also Figure S4.
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Figure 7. T-bet and Runx Transcription Factors Are Required for the Generation of IL-17A+IFN-g+ CD4+ T Cells during EAE
Flow cytometry analysis of cytokine-producing CD4+ T cells isolated from the central nervous system of Cd4-cre Tbx21fl/fl (A), Cd4-cre Runx1fl/fl (on Bcl2
transgenic background) (B), and Cd4-cre Runx3fl/fl (C) mice and their respective controls 17 days after MOG35-55 and CFA immunization. Data depict percent
cytokine-producing cells within CD4+ gate. Each symbol represents an individual mouse; small horizontal line indicates the mean. Graphs represent pooled data
of two independent experiments with 10–11 mice per experimental group (A and B) and one of two independent experiments (C). p values were determined by
Student’s t test.
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Generation of IFN-g-Producing Th17 Cellsof disease. Consistent with the negative regulatory role of T-bet
in the differentiation of Th17 cells (Lazarevic et al., 2011; Mukasa
et al., 2010), we observed a higher frequency of IL-17A+ cells in
the absence of T-bet. T-bet was required for development of
IL-17A+IFN-g+ and IFN-g+ cells (Figure 7A). In contrast, develop-
ment of IL-17A+ and IL-17A+IFN-g+ cells was dependent on
Runx1 (Figure 7B). There was also a significant reduction in the
frequency of IL-17A+IFN-g+ cells in Runx3-deficient mice (Fig-
ure 7C). We detected a reduced proportion of IL-17A+IFN-g+
cells in mice with a T cell-specific deletion of T-bet, Runx1, or
Runx3, suggesting that all three transcription factors regulate
the development of IL-17A+IFN-g+ cells during EAE (Figure 7).
Thus, we conclude that IL-17A+IFN-g+ cells are generated as a
result of a concerted action of T-bet and Runx transcription fac-
tors. In contrast, the development of IL-17A+ and IFN-g+ cells is
dependent on Runx1 and T-bet, respectively.
DISCUSSION
In this study, we have identified Runx1 and Runx3 transcription
factors as critical regulators of Th1-like Th17 cell differentiation.
We showed that ectopic expression of Runx transcription factors
in Th17 cells promoted the development of IFN-g-producingTh17 cells, which expressed high amounts of T-bet, STAT4,
and RORgt. Although ectopic expression of Runx1 or Runx3
induced both T-bet and STAT4, only T-bet (and not STAT4)
was required for maximal IFN-g production by Th1-like Th17
cells. T-cell-specific deletions of T-bet or Runx transcription fac-
tors impeded differentiation of Th1-like Th17 cells during EAE,
suggesting that such cells were generated as a result of a
concerted action of T-bet and Runx transcription factors. Our
mechanistic studies showed that exposure of Th17 cells to
IL-12 increased Runx1, Runx3, and Tbx21 expression in Th17
cells and enhanced binding of Runx1 to the Ifng promoter and
to major regulatory elements within the Ifng locus in a T-bet-
dependent manner. Thus, we have identified a transcription fac-
tor module consisting of Runx1, Runx3, and T-bet that supports
differentiation of Th1-like Th17 cells.
Fate-mapping experiments via Il17a-cre Rosa26eYFP reporter
mice have revealed that a significant proportion of IFN-g-pro-
ducing cells isolated from tissues with an ongoing inflammatory
response had expressed IL-17A at some point during their devel-
opment (Hirota et al., 2011). The acquisition of Th1 effector cell
functions by Th17 cells, including IFN-g expression, is crucial
for effective antitumor activity of Th17 cells, as indicated by the
fact that T-bet- or IFN-g-deficient Th17 cells had profoundlyImmunity 40, 355–366, March 20, 2014 ª2014 Elsevier Inc. 363
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Generation of IFN-g-Producing Th17 Cellsimpaired antitumor responses (Muranski et al., 2011). However,
Th1-like Th17 cells have also been implicated as major drivers of
immunopathology in multiple sclerosis (Kebir et al., 2009), rheu-
matoid arthritis (Nistala et al., 2010), colitis (Ahern et al., 2010;
Lee et al., 2009), and diabetes (Bending et al., 2009). The
transcription factor networks that regulate the developmental
program of Th1-like Th17 cells are poorly understood. Here we
showed that the coexpression of T-bet and RORgt was not suf-
ficient to establish a hybrid gene expression profile that would
give rise to CD4+ T cells equipped with Th1 and Th17 effector
cell functions. Instead, the differentiation of Th1-like Th17 cells
was controlled by T-bet and Runx transcription factors.
Runx1 and Runx3 are ubiquitously expressed in hematopoiet-
ic cells, including T cells, in which they play essential roles in
T cell development and the acquisition of T cell effector functions
(Collins et al., 2009). Runx transcription factors are relatively
weak transcriptional regulators on their own; thus, they regulate
gene expression in a context-dependent manner through inter-
actions with other transcription factors to activate or repress
gene expression (Mikhail et al., 2006). Runx proteins have
been shown to form transcriptional complexes with Foxp3,
RORgt, and T-bet to ensure appropriate Th cell differentiation
and cytokine production (Djuretic et al., 2007; Ono et al., 2007;
Zhang et al., 2008). For example, Runx3 interacts with T-bet to
promote Th1 cell differentiation through maximal activation of
Ifng and through repression of Il4 (Djuretic et al., 2007). Runx1
promotes Th17 cell differentiation by enhancing the expression
of the Th17-cell-specific transcription factor RORgt and by aug-
menting RORgt transcriptional activity at the Il17a locus (Zhang
et al., 2008). Based on these findings, we postulated that
Runx1 and Runx3 transcription factors could potentially support
the differentiation program that is characteristic of both Th1 and
Th17 cells depending on whether the Runx-interacting partner is
a Th1- or Th17-cell master transcription factor. In this scenario,
the differentiation of IL-17A+, IFN-g+, and IL-17A+IFN-g+ cells
would be determined by the relative molar ratios of T-bet,
RORgt, and Runx transcription factors in an activated CD4+
T cell. If the concentration of Runx1 is high enough to support
formation of both Runx1-T-bet and Runx1-RORgt transcription
complexes, then a Th cell that has the ability to simultaneously
express IFN-g and IL-17A will develop. In our study, ectopic
expression of Runx1 or Runx3 induced strong Tbx21 expression
in Th17 cells. Although T-bet is capable of epigenetically
silencing the Rorc locus in Th17 cells (Mukasa et al., 2010), we
found that both Runx1 and Runx3 maintained high levels of
Rorc expression in Th17 cells. This was necessary for stabilizing
the Th1-like Th17 cell state characterized by dual expression of
IFN-g and IL-17A. However, if the amount of Runx1 is limited and
the cells are activated in the presence of cytokines that induce
RORgt expression, then Runx1-RORgt interactions will promote
the differentiation of IL-17A+ cells. Conversely, the reactivation of
Th17 cells in the presence of IL-12 not only enhances T-bet
expression but also induces repressive epigenetic changes in
the Rorc locus (Mukasa et al., 2010), thus tipping the balance
toward the differentiation of IFN-g cells. Indeed, when we sorted
IL-17-expressing cells marked by Thy1.1 expression and
exposed them to IL-12, we observed that they gave rise to IL-
17A+IFN-g+ and IFN-g+ cells. This shift in cytokine production
was accompanied by an increase in Tbx21, Eomes, Runx1,364 Immunity 40, 355–366, March 20, 2014 ª2014 Elsevier Inc.and Runx3mRNA. All four transcription factors have been linked
to the regulation of Ifng; however, only Runx1 and Runx3 pro-
moted the differentiation of IL-17A+IFN-g+ cells in the absence
of IL-12 and independently of STAT4.
Although increased Runx1 or Runx3 expression was sufficient
to generate similar percentages of IL-17A+IFN-g+ and IFN-g+
cells in the absence of T-bet, the abundance of Ifng transcripts
was substantially diminished in T-bet-deficient Th17 cells trans-
duced with Runx1 or Runx3 compared to WT controls. These
data suggest that there is a requirement for T-bet and Runx1
coexpression for maximal induction of IFN-g in Th17 cells. This
conclusion is supported by loss-of-function genetic studies
that demonstrated that IL-12-mediated reprograming of Th17
cells into IFN-g-producing cells was severely impaired in the
absence of T-bet, Runx1, or Runx3. Previously, it has been
shown that treatment of Th17 cells with IL-12 led to the increased
binding of STAT4 and T-bet to the Ifng locus, which correlated
with the acquisition of permissive epigenetic marks and opening
of the Ifng locus (Mukasa et al., 2010). In this study, we provide
evidence for Runx1 binding to the Ifng promoter and at regula-
tory elements within the Ifng locus only in IL-12-treated Th17
cells, indicating that Runx1 may be directly involved in regulating
Ifng expression. Runx1 was dependent on T-bet for binding to
the Ifng promoter and regulatory elements that are normally
silenced in Th17 cells, because these require T-bet for IL-12-
induced changes from a repressive to permissive state.
By using the passive EAE model, we provide evidence that
T-bet and Runx transcription factors were indeed required for
the pathogenicity of adoptively transferred, MOG35-55-specific
cells, which correlated with the presence of dual expressing
IL-17A+IFN-g+ cells in the central nervous system. However,
the percentage of IFN-g+ cells was not affected by Runx1 defi-
ciency in the passive or active EAE models. In passive EAE,
approximately 60% of CD4+ T cells in ‘‘2D2 Bcl2+ Th17 + Runx
DN’’ culture did not produce IL-17A at the time of transfer. We
have shown by using IL-17F-Thy1.1 reporter mice that IL-17-
nonproducing cells (Thy1.1 negative) can give rise to IFN-g+ cells
when reactivated in the presence of IL-12. Similarly, immuniza-
tion of mice with MOG35-55 and CFA induces high levels of IL-
12 and IL-18, which drive the development of Th1 cells during
active EAE. Differentiation of Th1 cells is dependent on T-bet
and not on Runx1. In fact, we and others have shown that
Runx1 is not expressed in Th1 cells (Djuretic et al., 2007; Lazar-
evic et al., 2011). Thus, the results from passive and active EAE
experiments raise the possibility that a substantial portion of
IFN-g+ cells detected in the central nervous system could be
bona fide Th1 cells, whose development is T-bet dependent,
whereas the development of IL-17A+IFN-g+ (Th1-like Th17) cells
is dependent on both T-bet and Runx1.
In conclusion, we found that Runx1 contributes to the patho-
genicity and functional plasticity of Th17 cells. In overexpres-
sion studies, Runx transcription factors did not require IL-12
signaling, STAT4, or T-bet to promote the differentiation of
IFN-g-producing Th17 cells. Nevertheless, coexpression of
T-bet and Runx transcription factors was needed for maximal
production of IFN-g by Th1-like Th17 cells. This finding was a
consequence of enhanced Runx1 binding to the Ifng locus in
the presence of T-bet. Collectively, these studies highlight
Runx1 as a potential genetic risk factor for the development of
Immunity
Generation of IFN-g-Producing Th17 Cellsautoimmune diseases and beg for detailed analysis of Runx1
target genes in CD4+ T cells. The analysis of ChIP-seq data
sets from other transcription factors, such as RORgt and
T-bet, will reveal how T-bet-Runx1 and RORgt-Runx1 transcrip-
tional complexes orchestrate and coordinate T cell effector func-
tions during an inflammatory response, whether in the setting of
infectious or autoimmune diseases.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (WT) mice were purchased from Charles River Laboratories. Mutant
strains were kindly provided by the following researchers: Il17fThy1.1/Thy1.1
reporter (C. Weaver; University of Alabama at Birmingham) (Lee et al., 2009),
Stat4/ (J. O’Shea, MIIB, NIH), Tbx21fl/fl (S. Reiner, N. Cereb, S.Y. Yang,
and L. Boring) (Intlekofer et al., 2008), and Runx3fl/fl (D. Littman; NYU) (Egawa
et al., 2007). 2D2 TCR transgenic,Runx1fl/fl, andCd4-cremicewere purchased
from Jackson Laboratories and Bcl2 transgenic mice were obtained from
A. Singer (NCI, NIH). Animal experiments were approved by the NCI Institute
Animal Care and Use Committee.
Plasmids and Flow Cytometry
For a detailed list of plasmids and information about flow cytometry, see the
Supplemental Experimental Procedures.
Quantitative Real-Time PCR
mRNA was extracted from T cells with Qiazol (QIAGEN) and treated with
molecular grade DNase I (Roche) to eliminate possible genomic DNA contam-
ination. Reverse transcription was performedwith high-capacity cDNA reverse
transcription kit (Applied Biosystems). For quantitative RT-PCR, we used the
Syber Green PCR system (Applied Biosystems). The sequences of primers
are listed in Table S1.
Isolation, Differentiation, and Functional Analysis of CD4+ T Cells
Naive (CD62LhiCD25) CD4+ T cell purification from lymph nodes and spleens
of mice and culture conditions for Th cell differentiation are described in the
Supplemental Experimental Procedures.
Retroviral Transduction
See the Supplemental Experimental Procedures for details.
EAE Induction and Isolation of Central Nervous System Cells
Active EAE was induced by subcutaneous injection of mice with 100 mg
MOG35-55 peptide (MEVGWYRSPFSRVVHLYRNGK) emulsified in complete
Freund’s adjuvant supplemented with 250 mg Mycobacterium tuberculosis
extract H37Ra (Difco). Mice received 180 ng pertussis toxin (List Biological
Laboratories) intraperitoneally on days 0 and 2. For passive EAE experiments,
2D2 CD4+ T cells were activated and transduced under the Th17-cell-polar-
izing condition with either a control retroviral vector or retrovirus overexpress-
ing the Runx dominant-negative mutant. On day 2, mIL-23 (10 ng/ml; R&D
Systems) was added to retrovirally transduced 2D2 CD4+ T cells and cells
were expanded for additional 3 days. Five days after initial stimulation, cells
were sorted for GFP expression. Retrovirally transduced 2D2 T cells (>99%
GFP+) were reactivated on anti-CD3/CD28-coated plates (each at 2 mg/ml)
for 48 hr and injected into C57BL/6 or Rag2/Il2rg/ recipients (5 3 106/
mouse intravenously). Mice were monitored daily for the development of
EAE according to the following criteria: 0, no disease; 1, limp tail; 2, hind
limb weakness/partial paralysis; 3, complete hind limb paralysis; 4, front and
hind limb paralysis; 5, moribund state.
Chromatin Immunoprecipitation Assay
Chromatin was prepared from 1.5 3 107 of cells cultured under Th17 cell and
Th17 and IL-12 cell conditions as described above. In brief, cells were fixed
with 1% (vol/vol) methanol-free formaldehyde for 10 min at room temperature
and glycine was added to a final concentration of 0.125 M. Cell were washed
with cold 13 PBS followed by a 10 min lysis with 0.5% Triton-X on ice. Chro-
matin was sonicated to obtain fragments around 500 bp–1 kb in length viaUltrasonic Processor XL (Heat System). Chromatin was incubated with Protein
A beads coupled to anti-Runx1 antibody (Abcam; ab23980) overnight at 4C.
Beads were washed extensively and immunoprecipitated chromatin was
treated with Proteinase K overnight at 56C. DNA was extracted by phenol-
chloroform extraction followed by ethanol precipitation in the presence of
0.3 M sodium acetate and 20 mg of glycogen. Extracted DNA was analyzed
by real-time PCR with previously published primer sequences spanning the
Ifng promoter and Ifng-specific CNS regions (Mukasa et al., 2010). We used
the enhancer of Tcrb as a positive control and the Actb promoter as a negative
control (Rudra et al., 2009).
Statistics
Statistical significance was calculated by unpaired Student’s t test with Prism
software. All p values <0.05 are considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.immuni.2014.01.002.
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